Table 2

IC50s for human and canine osteosarcoma cell lines treated with doxorubicin or carboplatin ± taurolidine (inhibition curves shown in Figure2A and2B)
Cell line Doxorubicin (nM) Doxorubicin (nM) + 20 μM Taurolidine Carboplatin (μM) Carboplatin (μM) + 20 μM Taurolidine Carboplatin (μM) + 100 μM Taurolidine
Saos-2 252 22 198 204 0
D17 100 12 414 202 0
Clone-4 NR 4 538 134 0

NR = IC50 Not Reached.

Marley et al.

Marley et al. BMC Veterinary Research 2013 9:15   doi:10.1186/1746-6148-9-15

Open Data